Reperio Health, a connected at-home health assessment and biometric screening system raised $6 million in seed capital.
The seed round was co-led by Caduceus Capital Partners and Rogue Venture Partners with additional investment from Liquid 2 Ventures and G Ventures.
The company plans to use the new funds to accelerate growth and expand its health monitoring solutions to the employer market.
Reperio’s at-home health assessment enables employees and private individuals to perform a broad range of screenings. The company’s at-home health assessment test kit includes FDA-approved sensors, a blood test to measure levels of total cholesterol, HDL, LDL, triglycerides, and glucose, in addition to tests for blood pressure, resting heart rate, body mass index, and relative fat mass.
How it works
Reperio’s mobile app starts with a wellness screening to understand lifestyle patterns. Then, the connected-biometric screening walks customers through the testing process using voiceovers, animations, and videos to make the process as user-friendly as possible. Once they complete the full screening, the Reperio app provides them real-time results with the context that explains their results in an easy-to-understand format.
“Nearly 9 out of 10 large employers currently offer some sort of workplace wellness program, which equates to roughly 63 million people in the U.S. alone,” said Travis Rush, Reperio Health co-founder, and CEO. “Unfortunately, the typical process for health screenings is time-consuming and inconvenient, so many people procrastinate and put these off for years. Reperio is making it easy by bringing health screenings right to peoples’ door.”
In addition to the employer market, Reperio says the at-home health assessments will also be available to health plans, retirement facilities, fitness, and nutrition practitioners, and directly to individuals.
Rush added, “Employers understand the opportunity in helping employees proactively manage their health. It has been the catalyst for companies investing in a multitude of workplace wellness programs in recent years. We’ve seen the shift over the last decade to a higher adoption of virtual care and telehealth and realized that we could give people easier access to their data and ultimately, more control over their own health.”
Connected healthcare devices companies raised $471 million in 2020, compared to $556 million in 2019, a 15% decrease YoY. Recently, Cue Health, the creator of an app-connected health monitoring device system, raised $100 million in Series C funding. Investors include Foresite Capital, Decheng Capital, Madrone Capital Partners, Johnson & Johnson Innovation (JJDC), and ACME Capital.
